Suppr超能文献

自尊在首发精神病中的作用。

The role of self-esteem for outcome in first-episode psychosis.

机构信息

McGill University, PEPP Montréal, Douglas Hospital Research Centre, Montréal, Canada.

出版信息

Int J Soc Psychiatry. 2012 Jan;58(1):41-6. doi: 10.1177/0020764010382698. Epub 2010 Sep 8.

Abstract

BACKGROUND

Self-esteem may be associated with a wide range of psychiatric disorders, including psychotic disorders. However, the relationship between self-esteem and outcome in psychosis has not been adequately examined, especially early in the course of the illness.

AIM

The aim of the study was to examine the impact of self-esteem in individuals who presented for treatment of a first episode of psychosis on outcome early in the course of the illness.

METHODS

The Self-Esteem Rating Scale (SERS) was administered to 121 individuals with first-episode psychosis following entry into a specialized programme. Symptoms and the Global Assessment of Functioning (GAF) were assessed at six months after beginning treatment. A correlational analysis was followed by a linear regression controlling for potential confounds.

RESULTS

Self-esteem assessed early in the course of treatment was positively correlated with GAF at six months (r = 0.281, p < 0.01). A linear regression analysis conducted with GAF and depression at baseline in addition to gender, pre-morbid adjustment, duration of untreated psychosis (DUP), and self-esteem as predictors and GAF at six months as the outcome variable revealed only self-esteem to be a significant predictor of GAF at six months (β = 0.290, p < 0.01). However, no association was found between self-esteem and remission at six months (β = 0.003, p > 0.05).

CONCLUSION

Self-esteem is associated with global functional outcome at six months but not with remission of symptoms. Efforts should be made to provide interventions that may improve low self-esteem in the attempt to influence functional outcome.

摘要

背景

自尊可能与包括精神病性障碍在内的广泛精神障碍有关。然而,自尊与精神病患者预后之间的关系尚未得到充分研究,尤其是在疾病早期阶段。

目的

本研究旨在探讨首次出现精神病性症状的个体在疾病早期治疗时自尊对预后的影响。

方法

在专门的治疗项目中,对 121 名首次出现精神病性症状的个体进行了自尊评定量表(SERS)测试。在开始治疗后 6 个月时,评估了症状和总体功能评估(GAF)。首先进行相关性分析,然后进行线性回归,以控制潜在的混杂因素。

结果

治疗早期评估的自尊与治疗 6 个月时的 GAF 呈正相关(r=0.281,p<0.01)。对 GAF 与基线时的抑郁、性别、病前适应、未治疗精神病持续时间(DUP)以及自尊进行线性回归分析,并将 GAF 作为因变量进行分析,结果仅显示自尊是 6 个月时 GAF 的显著预测因素(β=0.290,p<0.01)。然而,自尊与 6 个月时的缓解之间没有关联(β=0.003,p>0.05)。

结论

自尊与 6 个月时的总体功能结局相关,但与症状缓解无关。应努力提供干预措施,以改善低自尊,从而影响功能结局。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验